Seres Therapeutics, Inc. Annual Nonoperating Income (Expense) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Seres Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2013 to 2023.
  • Seres Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$21.9M, a 712% decline year-over-year.
  • Seres Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$29.7M, a 5882% decline year-over-year.
  • Seres Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$5.74M, a 56.6% decline from 2022.
  • Seres Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$3.67M, a 238% decline from 2021.
  • Seres Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.09M, a 8.83% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.